Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02194062 · ClinicalTrials.gov registry record · NA
Comparison of Nasal Steroids After FESS in CRSwNP
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02194062 is a NA study that has completed, run by Yale University. The registered enrollment target is 32 participants.
The verdict
NCT02194062, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to compare intranasal fluticasone spray with budesonide nasal saline rinses in both the upright and head forward positions in patients who have had functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis with nasal polyposis (CRSwNP) and measure differences in Sinonasal Outcome Test-22 (SNOT-22) scores and Lund- Kennedy scores on rigid nasal endoscopy at time points 1 week, 3 weeks, 6 weeks, 2 months, 4 months, and 6 months post-op.
Interventions
- DRUG fluticasone nasal spray
- DRUG Budesonide head upright
- DRUG Budesonide head forward
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02194062
The ClinicalTrials.gov registry entry for NCT02194062 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which fluticasone nasal spray is the first listed.
NCT02194062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02194062 about?
NCT02194062 is a clinical study titled "Comparison of Nasal Steroids After FESS in CRSwNP". The purpose of this study is to compare intranasal fluticasone spray with budesonide nasal saline rinses in both the upright and head forward positions in patients who have had functional endoscopic sinus surgery (FESS) for chronic rhinosinusitis with nasal polyposis (CRSwNP) and measure differences...
What is the current status of trial NCT02194062?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2015-01. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02194062?
The interventions under investigation include: fluticasone nasal spray (DRUG), Budesonide head upright (DRUG), Budesonide head forward (DRUG).
Who is sponsoring clinical trial NCT02194062?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.